A detailed history of State Street Corp transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 1,113,590 shares of KROS stock, worth $18.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,113,590
Previous 1,221,376 8.82%
Holding current value
$18.6 Million
Previous $55.8 Million 15.86%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$41.68 - $58.07 $4.49 Million - $6.26 Million
-107,786 Reduced 8.82%
1,113,590 $64.7 Million
Q2 2024

Aug 14, 2024

SELL
$44.58 - $66.89 $15.2 Million - $22.8 Million
-341,519 Reduced 21.85%
1,221,376 $55.8 Million
Q1 2024

May 15, 2024

BUY
$41.26 - $70.48 $21 Million - $35.8 Million
508,528 Added 48.23%
1,562,895 $103 Million
Q4 2023

Feb 14, 2024

BUY
$27.12 - $41.05 $4.13 Million - $6.25 Million
152,367 Added 16.89%
1,054,367 $41.9 Million
Q3 2023

Nov 14, 2023

SELL
$31.57 - $43.02 $3.6 Million - $4.9 Million
-113,903 Reduced 11.21%
902,000 $28.8 Million
Q2 2023

Aug 14, 2023

BUY
$37.26 - $51.01 $2.67 Million - $3.66 Million
71,744 Added 7.6%
1,015,903 $40.8 Million
Q1 2023

May 15, 2023

SELL
$41.44 - $59.32 $993,689 - $1.42 Million
-23,979 Reduced 2.48%
944,159 $40.3 Million
Q4 2022

Feb 14, 2023

BUY
$39.45 - $51.77 $1.37 Million - $1.79 Million
34,626 Added 3.71%
968,138 $46.5 Million
Q3 2022

Nov 15, 2022

SELL
$27.8 - $40.12 $1.59 Million - $2.3 Million
-57,240 Reduced 5.78%
933,512 $35.1 Million
Q2 2022

Aug 15, 2022

BUY
$26.03 - $67.04 $7.99 Million - $20.6 Million
307,105 Added 44.92%
990,752 $27.4 Million
Q1 2022

May 16, 2022

BUY
$42.12 - $59.36 $1.21 Million - $1.7 Million
28,655 Added 4.37%
683,647 $37.2 Million
Q4 2021

Feb 14, 2022

SELL
$36.95 - $62.89 $823,098 - $1.4 Million
-22,276 Reduced 3.29%
654,992 $38.3 Million
Q3 2021

Nov 15, 2021

SELL
$29.27 - $43.71 $50,051 - $74,744
-1,710 Reduced 0.25%
677,268 $26.8 Million
Q2 2021

Aug 16, 2021

SELL
$42.4 - $70.11 $1.9 Million - $3.14 Million
-44,845 Reduced 6.2%
678,978 $28.8 Million
Q1 2021

May 17, 2021

BUY
$54.0 - $75.28 $16.1 Million - $22.4 Million
297,732 Added 69.88%
723,823 $44.6 Million
Q4 2020

Feb 16, 2021

BUY
$36.0 - $82.74 $11.8 Million - $27 Million
326,865 Added 329.41%
426,091 $30.1 Million
Q3 2020

Nov 10, 2020

BUY
$27.04 - $62.21 $384,373 - $884,315
14,215 Added 16.72%
99,226 $3.83 Million
Q2 2020

Aug 14, 2020

BUY
$20.08 - $40.39 $1.71 Million - $3.43 Million
85,011 New
85,011 $3.19 Million

Others Institutions Holding KROS

About Keros Therapeutics, Inc.


  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $430M
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.